Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Linichlorin A；Elegin | C19H23ClO6 | 62462-98-0 | Details |
| 3-Methyl-GABA | C20H30N2O10S2 | 71424-95-8 | Details |
| SGE-201；SGE201;SGE 201 | C26H44O2 | 35882-85-0 | Details |
| KW-2449 | C20H20N4O | 1000669-72-6 | Details |
| Lead salicylate；Salicylic acid, lead(II) salt;Lead(II) salicylate;Bis(salicylato)lead | C14H8O6Pb | 15748-73-9 | Details |
| RWJ 676070；RWJ-676070;RWJ676070 | C30H26ClFN2O5 | 813426-25-4 | Details |
| NPEC-caged-D-AP5 | C14H19N2O9P | 1416943-27-5 | Details |
| SMER3 | C11H4N4O2 | 67200-34-4 | Details |
| Dehydrocrenatidine；TOP-3;TOP3;TOP 3 | C15H14N2O2 | 65236-62-6 | Details |
| PD173952；PD 173952;PD-173952 | C24H21Cl2N5O2 | 305820-75-1 | Details |
| PF9 tetrasodium salt | C18H20N5O13P3 | 851265-78-6 | Details |
| Polmacoxib | C18H16FNO4S | 301692-76-2 | Details |
| MS-245；MS 245;MS245 | C19H22N2O3S | 263384-65-2 | Details |
| ADL-08-0011；ADL 08-0011 | C23H29NO3 | 156130-41-5 | Details |
| LAS38096；LAS-38096;LAS 38096 | C17H12N6O | 851371-22-7 | Details |
| Compound SC-1 | C21H13ClF3N3O2 | 1313019-65-6 | Details |
| TC-A 2317 hydrochloride | C19H29ClN6O | 1245907-03-2 | Details |
| NNC 63-0532 | C27H29N3O3 | 250685-44-0 | Details |
| Bam 12P；Bam12P;Bam-12P | C62H97N21O16S | 75513-71-2 | Details |
| OPC-14523 free base；OPC 14523;OPC14523;VPI-013;VPI013;VPI 013;OPC-14523 | C23H28ClN3O2 | 145969-30-8 | Details |
| SC-57461A；SC 57461A | C20H25NO3.ClH | 423169-68-0 | Details |
| LY-426965；LY426965;LY 426965 | C28H38N2O2 | 228418-82-4 | Details |
| Lapisteride | C29H40N2O3 | 142139-60-4 | Details |
| SB 268262 | C18H15N3O4S2 | 217438-17-0 | Details |
| TC 1698 dihydrochloride | C13H18N2 | 700834-58-8 | Details |
| Conoidin A | C10H8Br2N2O2 | 18080-67-6 | Details |
| 1-Methylpsilocin | C13H18N2O | 1465-16-3 | Details |
| Decane, 1,10-diiodo-；Decamethylene diiodide;1,10-Diiododecane | C10H20I2 | 16355-92-3 | Details |
| Levoleucovorin disodium；Disodium levofolinate | C20H21N7Na2O7 | 163254-40-8 | Details |
| SEN-1269；SEN 1269;SEN1269 | C18H18N4O2 | 956128-01-1 | Details |
| Leucinostatin；A 20668;A20668;A-20668 | C58H102N10O13 | 39405-64-6 | Details |
| Rubropunctatin；Rubropunctamine | C21H23NO4 | 514-66-9 | Details |
| JNJ-39393406 | C19H18F2N6O3 | 953428-73-4 | Details |
| PSB069 | C20H12ClN2NaO5S | 78510-31-3 | Details |
| Eeyarestatin I | C27H25Cl2N7O7 | 412960-54-4 | Details |
| LPYFD-NH2 | C33H44N6O8 | 700361-48-4 | Details |
| 5-BDBD | C17H11BrN2O2 | 768404-03-1 | Details |
| TCS 2314 | C28H34N4O6 | 317353-73-4 | Details |
| TUG-424 | C18H16O2 | 1082058-99-8 | Details |
| BIO-1211 | C36H48N6O9 | 187735-94-0 | Details |
| (S)-Mephenytoin | C12H14N2O2 | 70989-04-7 | Details |
| Hexylglutathione | C16H29N3O6S | 24425-56-7 | Details |
| Cardionogen 1 | C13H14N4OS | 577696-37-8 | Details |
| ML368 | C26H18N6O | 1361414-26-7 | Details |
| BI-6015；BI6015 | C15H13N3O4S | 93987-29-2 | Details |
| TP-353 | C35H30FNO3 | 1253799-29-9 | Details |
| Crovatin | C21H26O6 | 142409-09-4 | Details |
| RO495 | C17H14Cl2N6O | 1258296-60-4 | Details |
| Izonsteride | C24H26N2OS2 | 176975-26-1 | Details |
| AG2034；AG-2034;AG 2034 | C18H21N5O6S2 | 177575-17-6 | Details |
| LY-338979；LY338979;Pemetrexed 6-oxo diacid impurity;LY 338979 | C20H21N5O7 | 193281-00-4 | Details |
| SB-436811；SB 436811;SB436811 | C23H29Cl2N3O2 | 346729-66-6 | Details |
| CAA0225；CAA 0225;CAA-0225 | C28H29N3O5 | 244072-26-2 | Details |
| CEP-8983；CK-102;CEP 8983;CEP8983;CK 102;CK102 | C18H14N2O3 | 374071-46-2 | Details |
| NCDM-32B；NCDM32B;NCDM 32B | C15H30N2O4 | 1239468-48-4 | Details |
| GSK1104252A；GSK-1104252A;GSK 1104252A | C22H27FN4O5S | 1001397-20-1 | Details |
| Hoechst 33342 trihydrochloride | C27H29ClN6O | 875756-97-1 | Details |
| Varespladib methyl | C22H22N2O5 | 172733-08-3 | Details |
| GPR35 agonist 2 | C17H11FN2O3S | 494191-73-0 | Details |
| Ragaglitazar | C25H25NO5 | 222834-30-2 | Details |
| H2L 5765834 | C21H12N2O7 | 420841-84-5 | Details |
| AZD-1656；AZD 1656;AZD1656 | C24H26N6O5 | 919783-22-5 | Details |
| TDP665759；TDP 665759;JNJ-27291199;JNJ27291199;TDP-665759;JNJ 27291199 | C31H34Cl2IN5O2 | 787632-66-0 | Details |
| BI-10N；BI-10-N;BI 10 N;BI 10N;BI10N | C26H34N6O2S | 1149753-56-9 | Details |
| Muscarine iodide | C9H20INO2 | 24570-49-8 | Details |
| RuBi-GABA | C42H39F6N5O2P2Ru | 1028141-88-9 | Details |
| NBQX Disodium | C24H14N8Na2O12S2 | 479347-86-9 | Details |
| Amlodipine besilate impurity B；Amlodipine EP Impurity B | C29H32ClN3O7 | 721958-72-1 | Details |
| (-)-Irofulven；MGI114;NSC-683863;HMAF;MGI-114;Irofulven;MGI 114 | C15H18O3 | 158440-71-2 | Details |
| Teglarinad chloride | C30H43ClN5O8.Cl | 432037-57-5 | Details |
| Methylmethionine sulfonium chloride | C6H14ClNO2S | 1115-84-0 | Details |
| JNJ-2408068；HE066500;R-170591;R 170591;HE-066500;R170591;HE 066500 | C22H30N6O | 317846-22-3 | Details |
| KP-544；KP 544;KP544 | C18H19ClN4O | 393856-87-6 | Details |
| SF1126 | C39H48N8O14 | 936487-67-1 | Details |
| NVP-SAA164；NVP SAA164;SAA164;NVPSAA164;SAA-164;SAA 164 | C36H45N5O5S | 312722-60-4 | Details |
| PG-116800；PG 530742;PG 116800;PGE 7113313;PG-530742;PGE-7113313 | C24H27N3O7S | 291533-11-4 | Details |
| (S)-Warfarin | C19H16O4 | 5543-57-7 | Details |
| NK3201；NK-3201;NK 3201 | C31H29N5O6 | 204460-24-2 | Details |
| VUF 5574 | C21H17N5O2 | 280570-45-8 | Details |
| MI-2-2 | C17H20F3N5S2 | 1454920-20-7 | Details |
| S-4048；S 4048;S4048 | C32H30ClN3O7 | 173534-37-7 | Details |
| WAY 163909 | C14H18N2 | 428868-32-0 | Details |
| SEN12333 | C20H25N3O2 | 874450-44-9 | Details |
| JNJ1930942；JNJ 1930942;JNJ-1930942 | C16H11F4N3OS | 929562-28-7 | Details |
| GRN-529；GRN 529;GRN529 | C22H15F2N3O2 | 1253291-12-1 | Details |
| Tedalinab；GRC-10693 | C19H21F2N3O | 916591-01-0 | Details |
| Tyrosine kinase inhibitor | C31H31FN6O5 | 1021950-26-4 | Details |
| UNC569 | C22H29FN6 | 1350547-65-7 | Details |
| TAK-441；TAK441;TAK 441 | C28H31F3N4O6 | 1186231-83-3 | Details |
| Imatinib hydrochloride | C29H32ClN7O | 862366-25-4 | Details |
| Cobimetinib racemate | C21H21F3IN3O2 | 934662-91-6 | Details |
| Disopyramide phosphate；SC-13957;SC13957;SC 13957 | C21H32N3O5P | 22059-60-5 | Details |
| Metkephamid acetate；Lilly 127623;LY-127623;LY 127623;LY127623 | C31H44N6O8S | 66960-35-8 | Details |
| Pentamidine dihydrochloride | C19H26Cl2N4O2 | 50357-45-4 | Details |
| Eflucimibe | C29H43NO2S | 202340-45-2 | Details |
| Beloranib；ZGN 440;CKD-732 | C29H41NO6 | 251111-30-5 | Details |
| SKI 5C | C26H45NO4 | 120005-55-2 | Details |
| Phthalazinone pyrazole | C18H15N5O | 880487-62-7 | Details |
| Ebselen oxide | C13H9NO2Se | 104473-83-8 | Details |
| GW 610 | C15H12FNO2S | 872726-44-8 | Details |
| Product Total： Product Page： | ||||
| 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 | ||||